Published in J Biol Chem on June 20, 1997
The post-translational synthesis of a polyamine-derived amino acid, hypusine, in the eukaryotic translation initiation factor 5A (eIF5A). J Biochem (2006) 2.12
Posttranslational synthesis of hypusine: evolutionary progression and specificity of the hypusine modification. Amino Acids (2007) 1.57
Molecular cloning, expression, and structural prediction of deoxyhypusine hydroxylase: a HEAT-repeat-containing metalloenzyme. Proc Natl Acad Sci U S A (2005) 1.56
Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells. FEBS J (2006) 1.21
The hypusine-containing translation factor eIF5A. Crit Rev Biochem Mol Biol (2014) 1.14
Eukaryotic translation initiation factor 5A is involved in pathogen-induced cell death and development of disease symptoms in Arabidopsis. Plant Physiol (2008) 1.00
Complex formation between deoxyhypusine synthase and its protein substrate, the eukaryotic translation initiation factor 5A (eIF5A) precursor. Biochem J (1999) 0.92
Identification and characterization of a novel deoxyhypusine synthase in Leishmania donovani. J Biol Chem (2009) 0.91
Structure-function studies of human deoxyhypusine synthase: identification of amino acid residues critical for the binding of spermidine and NAD. Biochem J (2001) 0.84
Human deoxyhypusine synthase: interrelationship between binding of NAD and substrates. Biochem J (2000) 0.82
Comprehensive Structural Characterization of the Bacterial Homospermidine Synthase-an Essential Enzyme of the Polyamine Metabolism. Sci Rep (2016) 0.75
Transglutaminases. Annu Rev Biochem (1980) 3.47
The epsilon-(gamma-glutamyl)lysine crosslink and the catalytic role of transglutaminases. Adv Protein Chem (1977) 3.37
Polyamines as physiological substrates for transglutaminases. J Biol Chem (1980) 2.15
Mutants in three genes affecting transport of magnesium in Escherichia coli: genetics and physiology. J Bacteriol (1976) 2.09
Identification of hypusine, an unusual amino acid, in a protein from human lymphocytes and of spermidine as its biosynthetic precursor. Proc Natl Acad Sci U S A (1981) 1.95
Molecular and catalytic properties of transglutaminases. Adv Enzymol Relat Areas Mol Biol (1973) 1.77
Identification of the hypusine-containing protein hy+ as translation initiation factor eIF-4D. Proc Natl Acad Sci U S A (1983) 1.76
Features of the spermidine-binding site of deoxyhypusine synthase as derived from inhibition studies. Effective inhibition by bis- and mono-guanylated diamines and polyamines. J Biol Chem (1993) 1.74
In vitro anti-inflammatory effects of cynaropicrin, a sesquiterpene lactone, from Saussurea lappa. Eur J Pharmacol (2000) 1.70
Inhibition of the G1-S transition of the cell cycle by inhibitors of deoxyhypusine hydroxylation. Biochim Biophys Acta (1994) 1.62
Antiproliferative effects of inhibitors of deoxyhypusine synthase. Inhibition of growth of Chinese hamster ovary cells by guanyl diamines. J Biol Chem (1994) 1.58
Posttranslational synthesis of hypusine: evolutionary progression and specificity of the hypusine modification. Amino Acids (2007) 1.57
Mechanism and basis for specificity of transglutaminase-catalyzed epsilon-(gamma-glutamyl) lysine bond formation. Adv Enzymol Relat Areas Mol Biol (1983) 1.51
Hypusine: its post-translational formation in eukaryotic initiation factor 5A and its potential role in cellular regulation. Biofactors (1993) 1.49
Mechanism of action of guinea pig liver transglutaminase. I. Purification and properties of the enzyme: identification of a functional cysteine essential for activity. J Biol Chem (1966) 1.48
Deoxyhypusine hydroxylase from rat testis. Partial purification and characterization. J Biol Chem (1986) 1.44
Structural properties of guinea pig liver transglutaminase. J Biol Chem (1971) 1.42
Neuropathic pruritus following Wallenberg syndrome. Neurology (2009) 1.40
The biosynthesis of protein-bound hypusine (N epsilon -(4-amino-2-hydroxybutyl)lysine). Lysine as the amino acid precursor and the intermediate role of deoxyhypusine (N epsilon -(4-aminobutyl)lysine). J Biol Chem (1982) 1.39
Cloning and expression of human deoxyhypusine synthase cDNA. Structure-function studies with the recombinant enzyme and mutant proteins. J Biol Chem (1995) 1.39
Transglutaminase: mechanistic features of the active site as determined by kinetic and inhibitor studies. Biochim Biophys Acta (1966) 1.38
Comparison of the activities of variant forms of eIF-4D. The requirement for hypusine or deoxyhypusine. J Biol Chem (1991) 1.32
Relationships of the catalytic properties of human plasma and platelet transglutaminases (activated blood coagulation factor XIII) to their subunit structures. J Biol Chem (1974) 1.32
Transglutaminases. Methods Enzymol (1985) 1.29
Fecal carriage of serotype K1 Klebsiella pneumoniae ST23 strains closely related to liver abscess isolates in Koreans living in Korea. Eur J Clin Microbiol Infect Dis (2011) 1.28
Is hypusine essential for eukaryotic cell proliferation? Trends Biochem Sci (1993) 1.25
Degradation of ginseng saponins under mild acidic conditions. Planta Med (1982) 1.21
Differential effects and transport kinetics of ascorbate derivatives in leukemic cell lines. Anticancer Res (1998) 1.20
Cleavage of spermidine as the first step in deoxyhypusine synthesis. The role of NAD. J Biol Chem (1990) 1.19
Study on gelatin-containing artificial skin: I. Preparation and characteristics of novel gelatin-alginate sponge. Biomaterials (1999) 1.17
Transglutaminase-catalyzed cross-linking through diamines and polyamines. J Biol Chem (1978) 1.15
The biosynthesis of hypusine (N epsilon-(4-amino-2-hydroxybutyl)lysine). Alignment of the butylamine segment and source of the secondary amino nitrogen. J Biol Chem (1984) 1.14
Mechanism of action of guinea pig liver transglutaminase. VI. Order of substrate addition. J Biol Chem (1969) 1.13
Kinetic studies with transglutaminases. The human blood enzymes (activated coagulation factor 13 and the guinea pig hair follicle enzyme. J Biol Chem (1972) 1.13
Deoxyhypusine synthase from rat testis: purification and characterization. J Biol Chem (1995) 1.11
Regeneration of bovine and octopus opsins in situ with natural and artificial retinals. Biochemistry (1989) 1.10
Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: outcome of a phase I study. Hum Gene Ther (2001) 1.09
eIF5A isoforms and cancer: two brothers for two functions? Amino Acids (2011) 1.09
Reversal of the deoxyhypusine synthesis reaction. Generation of spermidine or homospermidine from deoxyhypusine by deoxyhypusine synthase. J Biol Chem (2003) 1.08
Structural features of the eIF-5A precursor required for posttranslational synthesis of deoxyhypusine. J Biol Chem (1994) 1.06
Conserved extended haplotypes of the major histocompatibility complex: further characterization. Genes Immun (2006) 1.06
Identification of a functional cysteine essential for the activity of guinea pig liver transglutaminase. J Biol Chem (1966) 1.05
Localization of phospholipase C-gamma1 signaling in caveolae: importance in EGF-induced phosphoinositide hydrolysis but not in tyrosine phosphorylation. FEBS Lett (2001) 1.05
gamma-Glutamylamine cyclotransferase: specificity toward epsilon-(L-gamma-glutamyl)-L-lysine and related compounds. Proc Natl Acad Sci U S A (1980) 1.04
N(epsilon)-(gamma-L-glutamyl)-L-lysine (GGEL) is increased in cerebrospinal fluid of patients with Huntington's disease. J Neurochem (2001) 1.04
Mechanism of the inactivation of guinea pig liver transglutaminase by 5,5'-dithiobis-(2-nitrobenzoic acid). J Biol Chem (1969) 1.03
Crystal structure of the NAD complex of human deoxyhypusine synthase: an enzyme with a ball-and-chain mechanism for blocking the active site. Structure (1998) 1.02
Tubulointerstitial disease in lupus nephritis: relationship to immune deposits, interstitial inflammation, glomerular changes, renal function, and prognosis. Nephron (1986) 1.02
Studies on gelatin-based sponges. Part III: a comparative study of cross-linked gelatin/alginate, gelatin/hyaluronate and chitosan/hyaluronate sponges and their application as a wound dressing in full-thickness skin defect of rat. J Mater Sci Mater Med (2001) 1.02
Transglutaminase from hair follicle of guinea pig (crosslinking-fibrin-glutamyllysine-isoenzymes-purified enzyme). Proc Natl Acad Sci U S A (1972) 1.01
Ginsenoside-Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phosphorylation and MAPK activation. Br J Pharmacol (2012) 1.01
Protransglutaminase E from guinea pig skin. Isolation and partial characterization. J Biol Chem (1990) 1.01
Savinin, a lignan from Pterocarpus santalinus inhibits tumor necrosis factor-alpha production and T cell proliferation. Biol Pharm Bull (2001) 1.00
Structural features of glutamine substrates for transglutaminases. Role of extended interactions in the specificity of human plasma factor XIIIa and of the guinea pig liver enzyme. J Biol Chem (1984) 1.00
Identification of a substrate site for liver transglutaminase on the aminopropeptide of type III collagen. J Biol Chem (1987) 0.99
HLA class II allele and haplotype frequencies in Koreans based on 107 families. Tissue Antigens (2002) 0.99
Gene discovery in oral squamous cell carcinoma through the Head and Neck Cancer Genome Anatomy Project: confirmation by microarray analysis. Oral Oncol (2003) 0.99
Mullerian adenosarcoma with sarcomatous overgrowth of the cervix presenting as cervical polyp: a case report and review of the literature. Int J Gynecol Cancer (2004) 0.98
Free and protein-conjugated polyamines in mouse epidermal cells. Effect of high calcium and retinoic acid. J Biol Chem (1988) 0.98
Multiplex assay to identify Korean vectors of malaria. Mol Ecol Resour (2010) 0.98
Purification from Fusobacterium mortiferum ATCC 25557 of a 6-phosphoryl-O-alpha-D-glucopyranosyl:6-phosphoglucohydrolase that hydrolyzes maltose 6-phosphate and related phospho-alpha-D-glucosides. J Bacteriol (1995) 0.97
Studies on gelatin-containing artificial skin: II. Preparation and characterization of cross-linked gelatin-hyaluronate sponge. J Biomed Mater Res (1999) 0.97
TNF-alpha and TGF-beta1 gene polymorphisms and renal allograft rejection in Koreans. Tissue Antigens (2004) 0.96
Fulminant type 1 diabetes in Korea: high prevalence among patients with adult-onset type 1 diabetes. Diabetologia (2007) 0.96
Structural features of glutamine substrates for human plasma factor XIIIa (activated blood coagulation factor XIII). J Biol Chem (1980) 0.95
Association of HLA class II genes with systemic sclerosis in Koreans. J Rheumatol (2001) 0.95
Eukaryotic initiation factor 4D. Purification from human red blood cells and the sequence of amino acids around its single hypusine residue. J Biol Chem (1986) 0.95
Deoxyhypusine synthase generates and uses bound NADH in a transient hydride transfer mechanism. J Biol Chem (2000) 0.95
Juxtaglomerular cell tumor of the kidney: a case report. J Korean Med Sci (2001) 0.94
Radiologic findings of renal hemangioma: report of three cases. Korean J Radiol (2001) 0.94
Diamine and triamine analogs and derivatives as inhibitors of deoxyhypusine synthase: synthesis and biological activity. J Med Chem (1995) 0.94
Representativeness of the "Ramfjord teeth" for epidemiologic studies of gingivitis and periodontitis. Community Dent Oral Epidemiol (1987) 0.94
In vitro inhibitory effect of protopanaxadiol ginsenosides on tumor necrosis factor (TNF)-alpha production and its modulation by known TNF-alpha antagonists. Planta Med (2001) 0.94
Identification of YHR068w in Saccharomyces cerevisiae chromosome VIII as a gene for deoxyhypusine synthase. Expression and characterization of the enzyme. J Biol Chem (1995) 0.94
Recent advances in calorie restriction research on aging. Exp Gerontol (2012) 0.93
Specific inhibition of eIF-5A and collagen hydroxylation by a single agent. Antiproliferative and fibrosuppressive effects on smooth muscle cells from human coronary arteries. J Clin Invest (1995) 0.93
Complex formation between deoxyhypusine synthase and its protein substrate, the eukaryotic translation initiation factor 5A (eIF5A) precursor. Biochem J (1999) 0.92
Pimarane cyclooxygenase 2 (COX-2) inhibitor and its structure-activity relationship. Bioorg Med Chem Lett (2001) 0.92
Serum aminopeptidases, "angiotensinase," and hypertension. I. Degradation of angiotensin II by human serum. Biochem Pharmacol (1965) 0.92
A reversible, calcium-dependent, copper-catalyzed inactivation of guinea pig liver transglutaminase. J Biol Chem (1969) 0.92
Rebamipide abolishes Helicobacter pylori CagA-induced phospholipase D1 expression via inhibition of NFκB and suppresses invasion of gastric cancer cells. Oncogene (2012) 0.91
Inter-examiner reliability in caries trials. J Dent Res (1979) 0.91
The Carroll rating scale for depression. II. Factor analyses of the feature profiles. Br J Psychiatry (1981) 0.91
Covalent incorporation of polyamines as gamma-glutamyl derivatives into CHO cell protein. Biochim Biophys Acta (1988) 0.90
Successful treatment of protein-losing enteropathy due to AA amyloidosis with somatostatin analogue and high dose steroid in ankylosing spondylitis. Clin Exp Rheumatol (2001) 0.90